ERBB2 and neoplasm: The distributions of tumor characteristics among cases were 7,648 ER positive (60.7%), 6,308 PR positive (50.1%), and 3,054 HER2 positive (24.3%) for participants included in the analysis of rs671 alone and, 1,871 ER positive (65.7%), 1,620 PR positive (56.9%), and 552 HER2 positive (19.4%) for those in the analysis of gene‐environment interaction, respectively.